ZIPRASIDONE
Introduction to Ziprasidone and Its Pharmacological Classification Ziprasidone, commonly known by its brand name Geodon, represents a significant advancement in the field of neuropsychopharmacology as a second-generation or atypical antipsychotic agent. Originally approved by the United States Food and Drug Administration (FDA) in 2001, this benzisothiazolyl piperazine derivative was developed to address the complex symptomatology […]